Adductor Canal Block and iPACK Pain Control in Total Knee Replacement
Official title: Comparison of the Efficacy and Safety of Three Adjuvant Strategies for ACB and iPACK Blocks in Patients Undergoing Elective Total Knee Arthroplasty: A Prospective, Randomized Clinical Trial
Run by Poznan University of Medical Sciences · NCT07677215 · Data updated 2026-11-12
This trial tests whether adding intravenous dexamethasone, with or without perineural dexmedetomidine, to ACB and iPACK blocks improves pain control and reduces opioid use after knee replacement.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years to 100 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Poznan University of Medical Sciences Academic / other |
| Locations | 2 sites (Lublin and 1 other locations) |
| Status | Recruiting |
| Started | May 20, 2026 |
| Main results expected | September 1, 2027 |
| Study ends | October 1, 2027 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07677215 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Candidates are adults aged 60–100 years undergoing planned unilateral primary TKA, ASA I–III, eligible for spinal anesthesia and ultrasound-guided blocks.
✕Probably not a fit
Patients with contraindications to spinal anesthesia, regional blocks, or study drugs, or with conditions that elevate risk for nerve blocks or anesthesia complications, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In adults undergoing elective total knee arthroplasty, the study compares three analgesia strategies using ultrasound-guided ACB and iPACK blocks with 0.2% ropivacaine: standard blocks, blocks plus intravenous dexamethasone, and blocks with intravenous dexamethasone plus perineural dexmedetomidine. All patients receive spinal anesthesia and ropivacaine for blocks. The primary outcome is total opioid consumption in the first 48 hours postoperatively; secondary outcomes include pain scores, duration of analgesia, time to first rescue analgesia, and quadriceps strength. The trial aims to optimize postoperative analgesia while supporting early mobilization and reducing opioid-related side effects. The investigation builds on prior evidence that dexamethasone and dexmedetomidine can prolong analgesia, exploring their combined effects in this regional anesthesia approach.
Why it matters
Potential benefit: If successful, the approach could provide longer-lasting pain relief and lower opioid needs after knee replacement.
How similar studies have gone: Previous studies suggest dexamethasone and dexmedetomidine can enhance regional block analgesia, but optimal combinations for ACB/iPACK in TKA require more evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 60 and 100 years * Scheduled for elective primary unilateral total knee arthroplasty * American Society of Anesthesiologists (ASA) physical status I-III * Ability to understand study procedures and provide written informed consent * Eligibility for spinal anesthesia and ultrasound-guided regional anesthesia according to institutional standards Exclusion Criteria: * Known allergy or hypersensitivity to ropivacaine, dexamethasone, dexmedetomidine, or any study-related medication * Contraindications to spinal anesthesia or peripheral nerve blocks * Coagulation disorders or anticoagulant therapy preventing safe regional anesthesia * Infection at the planned puncture site or systemic infection * Severe neurological disorders affecting lower limb sensory or motor function * Severe hepatic, renal, or uncontrolled cardiovascular disease * Clinically significant bradycardia or advanced atrioventricular conduction abnormalities * Chronic opioid use for more than 3 months before surgery * Uncontrolled diabetes mellitus or contraindications to dexamethasone administration * Inability or refusal to provide written informed consent
Where it's running
-
The John Paul II Catholic University of Lublin
Lublin, Poland Recruiting -
Poznan University of Medical Sciences
Poznan, Poland Recruiting
Study contacts
- Study coordinator: Malgorzata Reysner, MD PhD
- Email: mreysner@ump.edu.pl
- Phone: +48 61 8310122
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.